<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Coles NP</submitter><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>fcaf133</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11992568</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(2)</volume><pubmed_abstract>The aggregation of α-synuclein is a central neuropathological hallmark in neurodegenerative disorders known as Lewy body diseases, including Parkinson's disease and dementia with Lewy bodies. In the aggregation process, α-synuclein transitions from its native disordered/α-helical form to a β-sheet-rich structure, forming oligomers and protofibrils that accumulate into Lewy bodies, in a process that is thought to underlie neurodegeneration. Lipids are thought to play a critical role in this process by facilitating α-synuclein aggregation and contributing to cell toxicity, possibly through ceramide production. This study aimed to investigate biochemical changes associated with α-synuclein aggregation, focusing on lipid changes, using Raman spectroscopy coupled with machine learning. HEK293, </pubmed_abstract><journal>Brain communications</journal><pubmed_title>Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis.</pubmed_title><pmcid>PMC11992568</pmcid><funding_grant_id>BB/R013942/1</funding_grant_id><pubmed_authors>Quesnel A</pubmed_authors><pubmed_authors>Koss DJ</pubmed_authors><pubmed_authors>Coles NP</pubmed_authors><pubmed_authors>Angione C</pubmed_authors><pubmed_authors>Occhipinti A</pubmed_authors><pubmed_authors>Achadu O</pubmed_authors><pubmed_authors>Marles-Wright J</pubmed_authors><pubmed_authors>Kalesh K</pubmed_authors><pubmed_authors>Thomas AJ</pubmed_authors><pubmed_authors>Filippou PS</pubmed_authors><pubmed_authors>Outeiro TF</pubmed_authors><pubmed_authors>Khundakar AA</pubmed_authors><pubmed_authors>Islam M</pubmed_authors><pubmed_authors>Elsheikh S</pubmed_authors><pubmed_authors>Butler L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis.</name><description>The aggregation of α-synuclein is a central neuropathological hallmark in neurodegenerative disorders known as Lewy body diseases, including Parkinson's disease and dementia with Lewy bodies. In the aggregation process, α-synuclein transitions from its native disordered/α-helical form to a β-sheet-rich structure, forming oligomers and protofibrils that accumulate into Lewy bodies, in a process that is thought to underlie neurodegeneration. Lipids are thought to play a critical role in this process by facilitating α-synuclein aggregation and contributing to cell toxicity, possibly through ceramide production. This study aimed to investigate biochemical changes associated with α-synuclein aggregation, focusing on lipid changes, using Raman spectroscopy coupled with machine learning. HEK293, </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2025-07-13T03:04:15.123Z</modification><creation>2025-07-13T03:04:15.123Z</creation></dates><accession>S-EPMC11992568</accession><cross_references><pubmed>40226383</pubmed><doi>10.1093/braincomms/fcaf133</doi></cross_references></HashMap>